| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75735 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75733 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB300-221SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB6547T-100UG | |||
| Carrier Free | FAB6547R-100UG | |||
| Carrier Free | FAB6547G-100UG | |||
| Carrier Free | FAB6547V-100UG | |||
| Carrier Free | FAB6547U-100UG | |||
| Carrier Free | FAB6547N-100UG | |||
| Carrier Free | FAB6547S-100UG | |||
| Carrier Free | MAB6547-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-89417-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43922 | |||
| BSA Free | NBP2-52942-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43921 | |||
| BSA Free | NBP2-52941-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-17065-25ul | |||
![Analysis of cell line lysates probed with mouse mAb to GAPDH (theoretical molecular weight: 36 kDa), NB300-221, dilution 1:2,000: [1] protein standard, [2] HEK293, [3] HeLa, [4] SH-SY5Y, [5] COS1, [6] NIH-3T3, and [7] C6 cells. The GAPDH antibody reveals a single band at ~37 kDa in all cell lines. GAPDH is a house keeping protein, the level of which is relatively unaffected by most experimental manipulations, and, as a result, this antibody has been widely used as a western blotting loading control.](http://images.novusbio.com/fullsize/GAPDH-Antibody-1D4-Western-Blot-NB300-221-img0008.jpg)
![Western Blot: GAPDH Antibody (1D4) [NB300-221] - Notch1, ApoER2 & Dab1 colocalize in hippocampal neurons. (A) Representative image of fluorescent immunolabeling shows that Notch1 is localized in a subset of CA3 neurons, co-expressing Dab1 & ApoER2 (magnified insert). ApoER2 is highly expressed in all CA3 neurons. (B) Fluorescent immunolabeling shows the distribution of Notch1 & Dab1 as compared to Arc/Arg3.1 in CA3 neurons. (B′) Close up of a dendrite showing colocalization of the three proteins (white arrowheads). (C) Western blot analysis on immunoprecipitated samples from whole hippocampal lysate shows that Notch1 displays a strong interaction with Dab1 whereas Notch1 & ApoER2 interaction appears weaker in the preparation (n = 4 independent experiments). (D) Immunolabeling on immunoprecipitated samples from whole cortical lysates show that Notch1 & Dab1 interact. ApoER2 is bound to both Notch1 & Dab1 (n = 3 independent experiments). (E) Co-IP from synaptosomal membrane fractions reveals a stronger interaction between Notch1 & ApoER2, which is reduced in the N1cKO (n = 3 independent pulldowns). In (C–E) GAPDH is used as a loading control for the inputs & to detect contamination in the IP samples. Scale bar in (A) is 50 μm & (B) 25 μm. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26635527), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb300-221_mouse-monoclonal-gapdh-antibody-1d4-imgenex-img-5019a-310202416205131.jpg)
![Western Blot: GAPDH Antibody (1D4) [NB300-221] - Reduced expression of UNC5A in FancC−/− cells. a Reduced expression of Unc5A in brain cortex of FancC−/− mice compared to wild-type littermates. Western blotting was performed with the indicated antibodies. Each lane represents a different animal (WT: n = 6; FancC−/−: n = 8). b Bar graph represents ratio of Unc5A normalized to tubulin from WT (n = 6) & FancC−/− mice (n = 8). c Bar graph representation of UNC5A expression normalized to Sdha & Tbp from wild-type (WT) & FancC−/−-derived fibroblasts (n = 3). RLU: Relative light units. d–f HEK293T cells were transfected with UNC5AICD, FANCE & FANCC constructs expressing full-length FANCC (in d), FANCC1–306 (in e) or FANCC307–558 (in f). Constructs were transfected at a molecular ratio of 1:1:1 or with 10 times the molar amount of FANCE, FANCC or UNC5AICD as indicated in the figure. The total amount of transfected plasmid was equalized for all strategies with control empty vectors. Representative immunoblots performed with anti-HA (UNC5AICD), anti-FANCC, anti-FANCE or anti-GAPDH antibodies are shown. Arrows indicate appropriate protein bands. Bar graphs represent the mean fold change ± SEM of UNC5A protein levels normalized to GAPDH compared to 1:1:1 transfection controls in at least 4 separate experiments. *p < 0.05; **p < 0.005 Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30213274), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb300-221_mouse-monoclonal-gapdh-antibody-1d4-imgenex-img-5019a-310202416203715.jpg)
![Western Blot: GAPDH Antibody (1D4) [NB300-221] - Depletion of RAD21 & other cohesin subunits leads to differentiation of ESCs.(A): qPCR analysis of esiRNA knock-down efficiency for indicated genes (48 h RNAi, n = 3, error bars denote s.d. & *, ** indicate p<0.05 & 0.01 respectively). Transfection of a non-targeting esiRNA (Luc) was used as a control. Numbers adjacent to the gene names indicate independent, non-overlapping esiRNAs transfected. (B): Western Blot analysis of esiRNA knock-down efficiency for indicated genes (48 h RNAi; esi-1 & esi-2 indicate independent, non-overlapping esiRNAs transfected). Transfection of a non-targeting esiRNA (Luc) was used as a control. GAPDH served as a protein loading control. (C): Alkaline phosphatase staining of ESCs, which had been transfected with esiRNAs targeting RAD21, SMC1a & SMC3 (72 h post RNAi) showed a strong differentiation phenotype compared to a control (Luc). Nanog depletion served as a positive control for ESC differentiation. Scale bars correspond to 100 µm. (D): Quantification of alkaline phosphatase staining (n = 3) separated into undifferentiated (green), mixed (yellow) & differentiated colonies (red). (E+F): qPCR validation of expression changes of (E) stem cell maintenance genes & (F) lineage marker genes upon knock-down of RAD21 (two independent esiRNAs) & Luc control (48 h RNAi, n = 3, error bars denote s.d. & *, **, *** indicate p<0.05, 0.01 & 0.001 respectively). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/21589869), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb300-221_mouse-monoclonal-gapdh-antibody-1d4-imgenex-img-5019a-310202416205163.jpg)
![Western Blot: GAPDH Antibody (1D4) [NB300-221] - Application of the approach to other cell lines. (A) HT1080 cells (2 × 105) & HeLa cells (1 × 105) were plated in the wells of a 12 well plate & the digitonin concentration required for optimal extraction of the cytosol was determined as in Figure1. (B) The remainder of the protocol from Figure 2 was then applied using 100 μg/ml digitonin as the optimal cytosolic extract in each case. An aliquot of each extract was then analyzed by 4-12% SDS PAGE followed by Western blotting & probing with antibodies to GAPDH, BiP & Histone H3 (Used as an alternative nuclear marker due to weakness of the Lamin A signal in HeLa cells). (C) Samples were analyzed by 4-12% SDS PAGE followed by staining with Coomassie blue & then silver staining showing the difference in protein composition of each sample. The bracket alongside the gels marks the position of Histones in the RIPA nuclear extract & the asterisk next to the silver stained gels denotes protein bands unique to the E-RIPA extracts. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/20003239), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb300-221_mouse-monoclonal-gapdh-antibody-1d4-imgenex-img-5019a-3102024162187.jpg)
![Western Blot: GAPDH Antibody (1D4) [NB300-221] - Role of the TRIM11-USP14 axis in cell growth & apoptosis. a Levels of endogenous TRIM11 in HCT116 cells grown at 43 °C for 0 or 90 min, or at 43 °C for 90 min, & then at 37 °C for 60 or 120 min. b, c Levels of endogenous TRIM11 (b), or Flag-TRIM11, the indicated proteasome subunits, & USP14 (c) in the SN & P fractions of HCT116 cells with & without heat shock at 43 °C for 90 min. d, g TRIM11 overexpression (d) or knockdown (g) HCT116 cells & the corresponding control cells grown under unstressed, heat shock, & heat shock plus recovery conditions were analyzed for K48 polyUb conjugates & caspase-3 activation. e, f, h Apoptosis in TRIM11 overexpression (e, f) or knockdown (h) HCT116 cells, & the corresponding control HCT116 cells, treated with & without heat shock. i, j Caspase-3 activation (i) & apoptosis (j) in HCT116 cells expressing the indicated proteins and grown under normal or heat stress conditions. k–m K48 polyUb conjugates, caspase-3 activation (k), amyloid-like fibrils (l), & apoptosis (m) in HCT116 cells expressing the indicated proteins and grown under normal & heat stress conditions. In e, f, h, j, l, & m, data represent mean ± SEM (n = 3 unless otherwise indicated). *P < 0.05; **P < 0.01; ***P < 0.001. Uncropped blots are presented in Supplementary Fig. 14 Image collected & cropped by CiteAb from the following publication (//www.nature.com/articles/s41467-018-03499-z), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb300-221_mouse-monoclonal-gapdh-antibody-1d4-imgenex-img-5019a-310202416212324.jpg)
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP1-89417] - Staining of human kidney shows moderate to strong cytoplasmic/membranous positivity in cells in tubules.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-Immunohistochemistry-Paraffin-NBP1-89417-img0015.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP1-89417] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-Immunohistochemistry-Paraffin-NBP1-89417-img0016.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP1-89417] - Staining of human endometrium shows no positivity in glandular cells as expected.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-Immunohistochemistry-Paraffin-NBP1-89417-img0014.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP1-89417] - Staining of human testis shows no positivity in cells in seminiferous ducts as expected.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-Immunohistochemistry-Paraffin-NBP1-89417-img0017.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0631) [NBP2-52942] - Staining in human kidney and pancreas tissues. Corresponding SLC22A2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0631-Immunohistochemistry-Paraffin-NBP2-52942-img0010.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0631) [NBP2-52942] - Staining in human kidney and pancreas tissues. Corresponding SLC22A2 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0631) [NBP2-52942] - Staining of human kidney shows strong positivity in apical membrane in cells in tubules.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0631-Immunohistochemistry-Paraffin-NBP2-52942-img0007.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0631) [NBP2-52942] - Staining of human cerebral cortex shows strong membranous positivity in astrocytes.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0631-Immunohistochemistry-Paraffin-NBP2-52942-img0008.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0631) [NBP2-52942] - Staining of human pancreas shows no positivity in either exocrine or endocrine glandular cells as expected.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0631-Immunohistochemistry-Paraffin-NBP2-52942-img0009.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0628) [NBP2-52941] - Staining in human kidney and pancreas tissues. Corresponding SLC22A2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0628-Immunohistochemistry-Paraffin-NBP2-52941-img0010.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0628) [NBP2-52941] - Staining in human kidney and pancreas tissues. Corresponding SLC22A2 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0628) [NBP2-52941] - Staining of human kidney show strong positivity in apical membrane in cells in tubules.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0628-Immunohistochemistry-Paraffin-NBP2-52941-img0007.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0628) [NBP2-52941] - Staining of human cerebral cortex shows strong membranous positivity in astrocytes.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0628-Immunohistochemistry-Paraffin-NBP2-52941-img0008.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody (CL0628) [NBP2-52941] - Staining of human pancreas shows no positivity in either exocrine or endocrine glandular cells as expected.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-CL0628-Immunohistochemistry-Paraffin-NBP2-52941-img0009.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP3-17065] - Analysis in human kidney and tonsil tissues using Anti-SLC22A2 antibody. Corresponding SLC22A2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-Immunohistochemistry-Paraffin-NBP3-17065-img0004.jpg "Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP3-17065] - Analysis in human kidney and tonsil tissues using Anti-SLC22A2 antibody. Corresponding SLC22A2 RNA-seq data are presented for the same tissues.")
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP3-17065] - Staining of human kidney shows high expression.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-Immunohistochemistry-Paraffin-NBP3-17065-img0001.jpg)
![Immunohistochemistry-Paraffin: SLC22A2/OCT2 Antibody [NBP3-17065] - Staining of human tonsil shows low expression as expected.](http://images.novusbio.com/fullsize/SLC22A2-OCT2-Antibody-Immunohistochemistry-Paraffin-NBP3-17065-img0002.jpg)
![Western Blot: SLC22A2 Antibody [NBP1-59451] - HepG2 cell lysate, concentration 2.5 ug/ml.](http://images.novusbio.com/fullsize/SLC22A2-Antibody-Western-Blot-NBP1-59451-img0002.jpg "Western Blot: SLC22A2 Antibody [NBP1-59451] - HepG2 cell lysate, concentration 2.5 ug/ml.")
![Western Blot: SLC22A2 Overexpression Lysate (Adult Normal) [NBL1-16035] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for SLC22A2.](http://images.novusbio.com/fullsize/SLC22A2-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-16035-img0002.jpg "Western Blot: SLC22A2 Overexpression Lysate (Adult Normal) [NBL1-16035] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for SLC22A2.")